PCSK9 Inhibitors: Clinical Trials

5 trials of PCSK9 Inhibitors, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 2 recruiting, 1 unknown. 2 Phase 3, 1 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 32Not yet recruiting 1, Recruiting 1
Not applicable1Recruiting 1
Phase 41Unknown 1

Follow this drug Literature Review of PCSK9 Inhibitors trials Research Report on PCSK9 Inhibitors

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis
Treatment with PCSK9 inhibitors, Treatment without PCSK9 inhibitors - Aortic Stenosis, Calcific
Phase 3Not yet recruitingBeijing Anzhen Hospital1602026-04-012026-04-02
COAST Study - Cholesterol Optimization After Stroke
low-fat diet, supplements, statins, ezetimibe, bempedoic acid, PCSK9 inhibitors, fibrates, or other lipid-lowering agents - Stroke (CVA) or Transient Ischemic Attack, Cerebral Hemorrhage
Not yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS5002026-01-012025-12-01
Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography
PCSK9 inhibitors and background lipid-modifying therapy, Standard lipid-modifying therapy - Coronary Artery Disease, CT Angiography
Not applicableRecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine35962025-04-222026-02-06
Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients
Lipid-lowering therapy combination with PCSK9 inhibitors, bempedoic acid and ezetimibe, Lipid-lowering therapy combination with PCSK9 inhibitors and ezetimibe - Dyslipidemias, Statin Adverse Reaction
Phase 4UnknownUniversity of Salerno1302024-05-012024-04-24
Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis
PCSK9 inhibitors and statins with or without ezetimibe, Statins with or without ezetimibe - Aortic Stenosis
Phase 3RecruitingBeijing Anzhen Hospital1602024-03-222024-05-09

Conditions studied

Aortic Valve, Calcification of (2)  ·  Aortic Valve Stenosis (1)  ·  Cardiovascular Diseases (1)  ·  Cerebral Hemorrhage (1)  ·  Coronary Artery Disease (1)  ·  Dyslipidemias (1)  ·  Ischemic Attack, Transient (1)  ·  Lipid Metabolism Disorders (1)  ·  Stroke (1)

Sponsors

Beijing Anzhen Hospital (2)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  University of Salerno (1)

Countries

China (3)  ·  South Korea (1)

Top investigators

Zhijian Wang (2)  ·  Bon-Kwon Koo (1)  ·  Xiaoteng Ma (1)  ·  Xinyang Hu (1)

Results publications

PMID 25825402, PMID 40970544